News

Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide—a drug known as Zepbound—on weight loss ...
Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.
have become a focal point of both clinical and scientific research. FDA-approved peptides like Semaglutide and Tirzepatide, commonly used to treat type 2 diabetes and obesity, are available only ...
For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...